Torque Therapeutics, Inc.
Formerly TORQUE INC.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2019 | $38 M | No. 2 | $10 to $50 million | equity | SEC | |
| Aug 2015 | $46 M | No. 1 | $10 to $50 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Torque Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2019).
SEC Form D · Jul 2019
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jul 2019
That is all the official record says: Torque Therapeutics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Torque Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 8 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Bart Henderson | President and Chief Executive Officer | Jul 2019 |
| John G. Cox | Executive officer | Jul 2019 |
| Sok Cheng Soh | Treasurer | Jul 2019 |
| Bart B. Henderson | Mr. Henderson is the CEO and Treasurer of the Issuer. | Apr 2018 |
| Ulrik B. Nielsen | Mr. Nielsen is the President of the Issuer. | Apr 2018 |
| Keith B. Marshall | Mr. Marshall is the Chief Financial Officer of the Issuer. | Aug 2017 |
| Bart Henderson | President and Chief Executive Officer | Jul 2019 |
| Douglas A. Lauffenburger | Director | Jul 2019 |
| Douglas G. Cole | Director | Jul 2019 |
| John A. Hohneker | Director | Jul 2019 |
| John G. Cox | Director | Jul 2019 |
| John M. Dineen | Director | Jul 2019 |
| Bart B. Henderson | Mr. Henderson is the CEO and Treasurer of the Issuer. | Apr 2018 |
| Doug B. Cole | Director | Apr 2018 |
| Doug B. Lauffenburger | Director | Apr 2018 |
| John B. Dineen | Director | Apr 2018 |
| John B. Hohneker | Director | Apr 2018 |
| Ulrik B. Nielsen | Mr. Nielsen is the President of the Issuer. | Apr 2018 |
| Vikas B. Sinha | Director | Aug 2017 |
| Darrell B. Irvine | Director | Aug 2015 |
| Bart B. Henderson | Mr. Henderson is the CEO and Treasurer of the Issuer. | Apr 2018 |
| Ulrik B. Nielsen | Mr. Nielsen is the President of the Issuer. | Apr 2018 |